HKSE - Delayed Quote HKD

Dingdang Health Technology Group Ltd. (9886.HK)

0.365
+0.005
+(1.39%)
At close: May 9 at 3:28:26 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
4,669,078
4,669,078
4,856,806
4,329,075
3,678,690
Cost of Revenue
3,130,729
3,130,729
3,346,135
2,879,405
2,516,379
Gross Profit
1,538,349
1,538,349
1,510,671
1,449,670
1,162,311
Operating Expense
1,739,330
1,739,330
1,779,488
1,768,192
1,816,089
Operating Income
-200,981
-200,981
-268,817
-318,522
-653,778
Net Non Operating Interest Income Expense
19,834
19,834
24,749
9,233
-13,611
Pretax Income
-370,119
-370,119
-221,227
-2,832,147
-1,581,859
Tax Provision
9,867
9,867
9,641
10,128
17,115
Net Income Common Stockholders
-376,498
-376,498
-225,809
-2,833,395
-1,578,026
Diluted NI Available to Com Stockholders
-376,498
-376,498
-225,809
-2,833,395
-1,578,026
Basic EPS
-0.15
-0.28
-0.17
-3.37
-1.18
Diluted EPS
-0.15
-0.28
-0.17
-3.37
-1.18
Basic Average Shares
1,329,342.404
1,322,513.588
1,338,749.730
841,076.782
1,341,472.897
Diluted Average Shares
1,329,342.404
1,322,513.588
1,338,749.730
841,076.782
1,341,472.897
Total Expenses
4,870,059
4,870,059
5,125,623
4,647,597
4,332,468
Net Income from Continuing & Discontinued Operation
-376,498
-376,498
-225,809
-2,833,395
-1,578,026
Normalized Income
-23,527.250
-23,527.250
-232,628.750
-2,804,487
-1,560,248
Interest Income
28,725
28,725
32,628
17,151
4,165
Interest Expense
8,891
8,891
7,879
7,918
17,776
Net Interest Income
19,834
19,834
24,749
9,233
-13,611
EBIT
-361,228
-361,228
-213,348
-2,824,229
-1,564,083
EBITDA
-222,906
-222,906
-73,350
-2,688,922
-1,428,797
Reconciled Cost of Revenue
3,130,729
3,130,729
3,346,135
2,879,405
2,516,379
Reconciled Depreciation
138,322
138,322
139,998
135,307
135,286
Net Income from Continuing Operation Net Minority Interest
-376,498
-376,498
-225,809
-2,833,395
-1,578,026
Total Unusual Items Excluding Goodwill
-205,405
-205,405
9,093
-38,544
-23,704
Total Unusual Items
-6,488
-6,488
9,093
-38,544
-23,704
Normalized EBITDA
-216,418
-216,418
-82,443
-2,650,378
-1,405,093
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-51,351.250
-51,351.250
2,273.250
-9,636
-5,926
12/31/2021 - 9/14/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade